Eleven transposon mutant strains affected in bile acid catabolism were each found to form yellow, muconic-like intermediates from bile acids. To characterize these unstable intermediates, media from the growth of one of these mutants with deoxycholic acid was treated with ammonia, then the crude product was methylated with diazomethane. Four compounds were subsequently isolated ; spectral evidence suggested that they were methyl 12a-hydroxy-3-0x0-23,24-dinorchola-1,4-dien-22-oate, methyl 4-aza-12P-hydroxy-9( 10)-secoandrosta-1,3,5-triene-9,17-dione-3-carboxylate, methyl 4-aza-9a, 12P-dihydroxy-9( 1O)-secoandrosta-l,3,5-trien-l7-one-3-carboxylate and 4a-[3'-propionic acid]-5-amino-7P-hydroxy-7a~-methyl-3aa,4,7,7a-tetrahydro-1-indanone-6-lactam. It is proposed that the mutants are blocked in the utilization of such muconic-like compounds as the 3,12P-dihydroxy-5,9,17-trioxo-4(5),9( 10)-disecoandrosta-1( 10),2-dien-4-oic acid formed from deoxycholic acid. A further mutant was examined, which converted deoxycholic acid to 12a-hydroxyandrosta-1,4-dien-3,17-dione, but accumulated yellow products from steroids which lacked a 12a-hydroxy function, such as chenodeoxycholic acid. The products from the latter acid were treated as above; spectral evidence suggested that the two compounds isolated were methyl 4-aza-7-hydroxy-9( 10)-secoandrosta-1,3,5-triene-9,17-dione-3-carboxylate and 4a-[ l'a-hydroxy-3'-propionic acid]-5-amino-7a/3-methyl-3aa,4,7,7a-tetrahydro-1 -indanone+lactam.
INTRODUCTION
In the initial stage of catabolism of the bile acids by Gram-negative micro-organisms, reactions at the two ends of the bile acid molecule occur concurrently (Fig. 1) . This results in the dehydrogenation of the A ring, and in side-chain removal, to produce the epimeric androstane compounds (2) and (3) (Leppik, 1983 , and references therein). The B ring is then opened, to give initially the secophenol (4) (Leppik, 1981; Park, 1984) , then the secocatechol (5) (Park et al., 1988) . This is followed by removal of the A ring carbons (except C-5) as the next, and most degraded, pathway intermediate to have been reported is the &lactone of the indane acid (8) (Leppik, 1981) .
Recently, transposon mutagenesis studies have begun (Ide et al., 1986; Leppik & Sinden, 1987) , and the results obtained support the postulated pathway of Fig. 1 . In this laboratory, almost 200 Tn5 and Tn5-Mob transposon mutants affected in bile acid catabolism have now been isolated, from four phenotypically different Pseudomonas spp. The mutants were divided into groups, and strains in two of the groups were shown to accumulate either 12P-hydroxyandrostane compounds (3B-D), or secophenols (4B-D), when grown in the presence of the bile acids (1B-D) (Leppik & Sinden, 1987) . Two further groups examined both accumulated 12a-hydroxyandrosta-1,4-diene-3,17-dione (2B) from deoxycholic acid (1 B), but one group was able to grow on steroid substrates which lacked a l2a-hydroxy group, whereas the single member of the second group, RAL8.23, accumulated yellow products from such steroids as chenodeoxycholic acid (1C) (Leppik & Sinden, 1987) . In this paper, a further group of Tn5 transposon mutants is described, and the yellow disecoandrostane compounds accumulated by one of these mutants, RAL8 .17, and also that accumulated by the above mutant, RAL8.23, are characterized. In the accompanying paper, the cellular location of the bile acid catabolic genes is examined, and the cloning of a chromosomal DNA segment coding for at least two of these genes, including the gene mutated in RAL8.17, is described (Leppik, 1989) . dispensed into six x 2 litre conical flasks, and shaken (200 r.p.m.) at 25 "C. Growth was followed both by TLC examination of ethyl acetate extracts of acidified medium samples, and also by purification of a sample (2 ml) of the medium using a Waters Sep-Pak C18 cartridge (Leppik et al., 1982) . A portion (100 pl) of the yellow methanol eluate (4 ml) obtained from the Sep-Pak cartridge was diluted into 0-01 M-sodium hydroxide solution (2 ml), then examined spectroscopically at 394 nm. The absorbance reached a maximum after 22.5 h, by which time there was only a low level of precursors remaining, as judged by TLC. The culture was centrifuged to remove the cells, concentrated ammonia solution (220ml) added to the supernatant, and the mixture left overnight at room temperature. After evaporation to approximately half-volume to remove the ammonia, the mixture was loaded onto an Amberlite XAD-2 column (250 g). The latter was washed with water (1 litre), then with a gradient of 5-12% (v/v) ethanol in water. Those fractions that contained a peak at 270 nm were combined and evaporated. The dried extract (2.62 g) was mixed with ethanol, methylated with diazomethane, then evaporated. The methylated product was purified by passage through a Merck Kieselgel60 column (85 g), with a gradient of 1 4 % (v/v) ethanol in chloroform. Three main fractions were obtained, the second and third of which each appeared to contain essentially one compound. The first fraction was found by TLC to be a mixture of two compounds; these were separated by passage through a second Kieselgel60 column (50 g), which was eluted with a gradient of 15-100% (v/v) ethyl acetate in hexane. The four compounds obtained are listed below in order of elution, the two compounds from the second column, then the two from the second and third fractions of the first column.
Methyl I2a Isolation of the chenodeoxycholic acid products from RAL8.23. Growth conditions were as for RAL8.17, except that chenodeoxycholic acid (1C) (5 mM) replaced deoxycholic acid, the pH of the minimal medium was raised from 7.4 to 8.2, and the ammonium chloride concentration in the minimal medium was increased from 19 m~ to 60 mM. After 20 h, the absorption at 390 nm was dropping, and there was only a low level of precursors remaining, as judged by TLC, so the culture was centrifuged and concentrated ammonia solution (220ml) added to the supernatant; the mixture was then left at room temperature overnight. Excessive frothing prevented evaporation of the mixture to half-volume, so the mixture was adjusted to pH 7.0 with glacial acetic acid, then purified using Amberlite XAD-2 column chromatography, as described above, except that a gradient of 2-100% (v/v) methanol in water was used. The fractions with an absorbance maximum at 270 nm were combined, dried, dispersed in aqueous methanol, then methylated with diazomethane. The methylated product (2-91 g) was purified by passage through a Merck Kieselgel 60 column (85 g), with a gradient of 1 4 % (v/v) ethanol in chloroform. Two main compounds were obtained, which are described below in order of elution.
Methyl 4-aza-7-hydroxy-9( lO)-secoandrosta-l,3,5-trien-9,17-dwne-3-carboxylate (compound 12C). This compound (0.59 g) was recrystallized from an ethyl acetate/hexane mixture [yield 0.45 g, m.p. 150-150.5 "C (decomposition)].
It had the following properties: A,,,,,. 230 nm (E 8900 1 mol-l cm-l), 272 nm (E 5700 1 mol-l cm-l); IRmax. (cm-') 3740 (OH), 1736 [C=O, C(17) 
RESULTS

Mutant strains that form a disecoandrostane compound (6B) from deoxycholic acid (IB)
Eleven transposon mutant strains were isolated which turned the medium yellow when grown in the presence of a bile acid. All produced slight growth when plated onto minimal medium containing either deoxycholic acid (1 B) or 12a-hydroxy-3-oxochola-1,4-dien-24-0ic acid, and negligible growth on plates containing either 3a-hydroxy-5~-androstan-l7-one or androsta-l,4-diene-3,17-dione (3A). This suggested that the mutants were blocked in ring degradation (Leppik & Sinden, 1987) .
The eleven strains were each grown in minimal medium containing glucose (5 m) and deoxycholic acid (2-5 mM), and samples taken at 24 h. The samples were acidified, extracted with ethyl acetate, and the extracts examined by TLC. No spots could be seen for any strain, except for a dark spot at the origin. Samples were also purified via a Waters Sep-Pak CI8 cartridge (Leppik et al., 1982) . The yellow methanol eluates, after dilution into 0.01 M-sodium hydroxide solution, showed A, , , . values of 393-396 nm. These maxima are in the same position as that reported for 3-hydroxy-5,9,17-triox0-4(5),9( 10)-disecoandrosta-1 (1 0),2-dien-4-oic acid (6A) (Gibson et al., 1966) , suggesting that the eleven mutant strains accumulated the analogous compound (6B) from deoxycholic acid (1B).
Stability of the yellow product formed from deoxycholic acid
The disecoandrostane compound studied by Gibson et al. (1 966) was reported to be unstable, so the stability of the product from deoxycholic acid was examined, as a prelude to its characterization. One of the mutant strains, RAL8.17, was grown for 24 h in minimal medium containing glucose (5 m~) and deoxycholic acid (10 m~) , by which time the compounds absorbing at 394nm were at about their maximum concentration. The yellow medium was centrifuged, the supernatant filter-sterilized, and then a few drops of chloroform were added to ensure sterility. Samples were taken at various times, diluted into 0.01 M-sodium hydroxide solution, then read at 394 nm. It was found that the absorbance at 394 nm dropped at the rate of approximately 13% per hour, showing that there would be an approximately 50% loss in the yellow products in 5 h.
Isolation of the intermediates formed by M U . I7 from deoxycholic acid
Because of the instability of the products, it was necessary to convert them into more stable compounds. One method of achieving this could be by reaction with ammonia, as Gibson et al. (1966) had shown that the disecoandrostane compound (6A) reacts with ammonia to form a stable pyridine acid (1 1A) (Fig. 2) , the latter having a Lax. of 273 nm. Strain RAL8 .17 was grown in minimal medium containing glucose (5 mM) and deoxycholic acid (10 mM), and growth was followed as described above. The absorbance at 394 nm reached a maximum after 22.5 h, when the culture was centrifuged, concentrated ammonia solution added to the supernatant, and the mixture left at room temperature. After 20 h, the 394 nm peak had disappeared, and a shoulder had appeared at 270nm. The mixture was evaporated to approximately half-volume to remove excess ammonia, then purified by XAD-2 column chromatography. Those fractions with an absorbance maximum I at 272 nm were combined, dried, mixed with ethanol, and treated with diazomethane. The methylated products were then purified by silica gel column chromatography, to yield four main, products.
Spectral examination of the first compound to be eluted from the silica gel column indicated that it contained a 1,4-dien-3-one function [ A, , , . 242 nm ( E 19900 1 mol-l cm-l); NMR, 6 (p.p.m. (87)]. This suggested that the compound was methyl 12a-hydroxy-3-oxo-23,24-dinorchola-l,4-dien-22-oate, and this was confirmed by comparison with the compound previously isolated from RAL8 (Leppik, 1983) .
The spectral data of the second compound to be eluted indicated that it was the pyridine methyl ester compound (12B). Thus, it had the following properties: Lax. (Fig. 3) , which showed a parent ion at m/z 359-1730, which corresponds to C20H2505N, and a base peak at m/z 178.0872, which corresponds to
The third compound to be eluted also appeared to be a pyridine methyl ester (relevant spectral data similar to that of compound 12B) but appeared to contain only one carbonyl function . This is compatible with the compound being methyl 4-aza-9a, 12P-dihydroxy-9( l0)-secoandrosta-l,3,5-trien-l7-one-3-carboxylate (compound 15, Fig. 4 ). This assignment is supported by the mass spectrum (Fig. 4) , which showed a parent ion at m/z 361.1893, which corresponds to C20H2705N. The difference in the mass spectral patterns (rig. JJ, ana tne secophenol compound (4B) (Leppik, 1981) , and those that contain a 9-hydroxy function, such as compound (15) (Fig. 4) , is striking, and is indicative of the strong influence that the 9-keto function has on the fragmentation pattern.
High-resolution mass spectral examination of the final compound to be eluted showed a parent ion at m/z 235-1202, which corresponds to Cl3HI7O3N. This, and the NMR data in particular, indicated that the compound could be the 6-lactam compound (14B) [NMR, 6 7.47 (1 H, broad s, disappears after D 2 0 exchange, NH), 4.77 (1 H, d of d, J2,2 Hz, C(6)H), 4.49 (1 H d of d, J2,2 Hz, C(7a)H), 1.02 (s, 7aPCH3). This structural derivation is supported by comparison with the spectral data published for the &lactam (14A) by Hayakawa et al. (1976) . In particular, compound (14A) is reported to have a Amax. at 230.5nm (E 138001 mol-l cm-l), and the compound isolated here (14B) has a Amax. at 230 nm (E 16 100 1 mol-l cm-l). m~e r gruwin 01 KALU. I I as aescriDea aoove, me yieias 01 me main proaucts otxainea oy silica gel chromatography were quite low -5.1 % for the pyridine derivative (1 2B), and 4.8 % for the lactam (14B). Whilst this is largely a reflection of the instability of the disecoandrostane (6B), it was considered that the yield of products might be improved by increasing the concentration of free ammonia in the medium. This could be achieved both by raising the pH, and by raising the concentration of ammonium chloride. Tests showed that the parent strain RAL8 could grow satisfactorally at pH values up to 8.2, and at ammonium chloride concentrations up to 60 mM, as against the normal M9 medium of pH 7.4 and 19 mM-ammOniUm chloride. This would result in an increase in the free ammonia concentration from approximately 0.2 mM to approximately 6 mM. Preliminary experiments with RAL8. 17 indicated that at pH8.2 and 60 mM-ammonium chloride, there was an approximate two fold increase in the product yield of the pyridine derivative (12B), so these conditions were used in the growth of RAL8. 23 described below.
3i1ai11 nI-ILo. LJ nas wen previously reporrea to conven aeoxycnoiic acia (ifs) into i~a -hydroxyandrosta-1,4-diene-3,17-dione (2B), but to form a yellow product when grown with chenodeoxycholic acid (1C) (Leppik & Sinden, 1987) . To identify the yellow product, RAL8.23 was grown in minimal medium, pH 8.2, containing glucose (5 mM), chenodeoxycholic acid (5 mM) and ammonium chloride (60 mM). Growth was monitored, and the products isolated, as described for RAL8.17. Two main compounds were isolated.
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The first compound to be eluted from the silica gel column was found to be a pyridine methyl ester, and to contain two carbonyl functions (relevant spectral data similar to that of compound 12B). The compound also contained an hydroxy function (IRmax. 3740 cm-l ; NMR, 6 (p.p.m.) 5.39 (lH, d, J 4 Hz, disappears after D 2 0 exchange, C(7)OH), 4-56 (lH, m, C(7)H)l. These results are compatible with the compound being the pyridine ester (12C). This is supported by the mass spectrum, which showed a small parent ion at m/z 359.1689, which corresponds to C20H2505N. The mass spectrum contained four major peaks, three of which, at m/z 105, 133 and 165, were at the same positions as that obtained for compound (12B) (Fig. 3) . The fourth major peak, at m/z 194.0819, corresponds to CloHl 2O3N, and could be equivalent to the m/z 178 peak of compound (12B), but containing the extra oxygen atom originally present at C(7) in chenodeoxycholic acid (1C).
The second compound to be eluted had a parent ion in the mass spectrum at m/z 235.1207, which corresponds to C13H1703N. Thus the compound could be the 6-lactam (14C); this is supported by comparison of the spectral data with that of the 6-lactam (14B), described above. Thus, it has a Amax. at 228 nm (8 14900 1 mol-l cm-l), and NMR peaks at 6 7.43 (IH, broad s, disappears after D 2 0 exchange, NH), The yield of the products obtained in this experiment was found to be higher than that obtained after growth of RAL8.17, and may reflect the increased concentration of free ammonia in the medium. Thus, the yields, after isolation, of the pyridine derivative (1 2C) and the d-lactam (14C) were 17% and 8.4%, respectively compared with 5.1 % for the pyridine derivative (12B) and 4.8% for the d-lactam (14B), as reported above.
DISCUSSION
The microbial degradation of aromatic compounds frequently occurs via their conversion into phenolic, then catecholic, intermediates, followed by the cleavage of the aromatic ring (Bayly & Barbour, 1984) . This mode of degradation is also found as part of the steroid catabolic pathway, where the rupture of the B ring (Fig. 1) initially produces phenolic secosteroids such as compound (4). The first report of such secosteroids was by Dodson & Muir (1958) , who isolated the secophenol4A after fermentation of androst-4-ene-3,17-dione by a Pseudomonas sp. Similar secophenols have been isolated from other androstane substrates (Schubert et al., 1960; Wang & Sih, 1963) , from progesterone (Schubert et al., 1961) , and from bile acids (Leppik, 1981 ; Park, 1984) .
Evidence that the phenolic secosteroids were then hydroxylated to catecholic secosteroids was obtained by Sih et al. (1966) , who synthesized the secocatechol @A), and demonstrated its conversion into the indane acid (7A) by cell extracts of Nocardia restrictus. Direct evidence for the intermediacy of secocatechols, however, has only recently been obtained, when it was found that certain P. putida mutant strains would accumulate the secocatechol(5D) when grown in the presence of cholic acid (1D) (Park et al., 1988) .
The cleavage of catechol rings can occur either between the two hydroxy groups (orthocleavage), or to one side of the diol grouping (meta-cleavage). Of the two, meta-cleavage has been found to be used for the degradation of a wider range of compounds than has ortho-cleavage (Bayly & Barbour, 1984) . Evidence that steroid secocatechols also undergo meta-cleavage was obtained by Gibson et al. (1966) , who demonstrated that cell extracts of N. restrictus could convert the synthetic secocatechol(5A) into the disecoandrostane (6A), the latter being isolated as its pyridine derivative (11A).
The results presented in this paper show that meta-cleavage of the aromatic A ring is also an integral part of the bile acid degradative path. Thus, eleven transposon mutant strains, isolated from four phenotypically different Pseudomonas spp., were each found to accumulate a yellow product from deoxycholic acid (1B). The UV absorption spectra suggested that this product could be the disecoandrostane (6B). This was confirmed for one of the mutants, RAL8.17, where the major yellow compound present was isolated as the pyridine methyl ester derivative (1 2B).
